Immunogenicity and safety of two doses of SARS‐CoV‐2 mRNA vaccine in kidney transplant recipients with low‐dose rituximab-Reference-Cited by-同舟云学术

Immunogenicity and safety of two doses of SARS‐CoV‐2 mRNA vaccine in kidney transplant recipients with low‐dose rituximab

Published:2022-07-21 Issue:11 Volume:29 Page:1279-1286
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:Int J of Urology

Author:

Takai Satoshi¹,Nishida Hayato¹^ORCID,Ito Hiromi¹,Fukuhara Hiroki¹,Nawano Takaaki²,Narisawa Takafumi¹,Kanno Hidenori¹,Yagi Mayu¹,Yamagishi Atsushi¹,Sakurai Toshihiko¹,Naito Sei¹,Kato Tomoyuki¹,Morikane Keita³,Tsuchiya Norihiko¹^ORCID

Affiliation:

1. Department of Urology Yamagata University Faculty of Medicine Yamagata Japan

2. Department of Cardiology, Pulmonology, and Nephrology Yamagata University Faculty of Medicine Yamagata Japan

3. Division of Clinical Laboratory and Infection Control Yamagata University Hospital Yamagata Japan

Publisher

Wiley

Subject

Urology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/iju.14978

Reference23 articles.

1. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

2. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

3. BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

4. COVID-19 vaccination in kidney transplant recipients

5. Two Doses of SARS-CoV-2 Vaccines Reduce Risk of Death Due to COVID-19 in Solid Organ Transplant Recipients: Preliminary Outcomes From a UK Registry Linkage Analysis

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rituximab‐to‐vaccine interval on SARS‐CoV‐2 immunogenicity in children: The potential role of prior natural infection;Pediatric Allergy and Immunology;2024-05

2. Cellular immune response of SARS-CoV-2 vaccination in kidney transplant recipients: a systematic review and meta-analysis;Frontiers in Immunology;2023-07-26

3. Optimal time for COVID-19 vaccination in rituximab-treated dermatologic patients;Frontiers in Immunology;2023-03-15

4. Antibody acquisition after second and third SARS-CoV-2 vaccinations in Japanese kidney transplant patients: a prospective study;Clinical and Experimental Nephrology;2023-03-13

5. Effectiveness of BBIBP-CorV vaccine in preventing SARS-CoV2 infection and severe outcomes in people living with multiple sclerosis: A population-based study;Multiple Sclerosis and Related Disorders;2023-03